131 articles - From Friday Nov 14 2025 to Friday Nov 21 2025
Guidelines and related publications, position statements, white papers, technical reviews, consensus statements, etc…
| Gastrointest Endosc |
|---|
| Establishing Standards of Practice for Transoral Outlet Reduction: An Expert Consensus using a Modified Delphi Method.
These standards provide step-by-step TORe guidance for safe and effective clinical outcomes. |
| J Hepatol |
| EASL Clinical Practice Guidelines on vascular diseases of the liver.
Multidisciplinary management involving hepatologists, haematologists, pathologists, interventional radiologists and surgeons is essential in this area. Our aim is to provide guidance on the management of patients with vascular liver diseases based on the best available evidence. |
meta-analyses and systematic reviews
| Aliment Pharmacol Ther |
|---|
| Meta-Analysis: Liver Disease Burden and Associated Factors in Turner Syndrome.
Liver disease is common in individuals with TS, with a 4-6 times higher risk than age-matched healthy females. X chromosome abnormalities are more strongly associated with an increased liver disease risk than hypogonadism. |
| Gastrointest Endosc |
| Identifying the Optimal Bowel Prep for Small-Bowel Capsule Endoscopy: A Meta-Review and Umbrella Meta-Analysis.
This study demonstrates that purgative bowel preparation, particularly with PEG, is superior to fasting alone in improving adequate SB cleansing and diagnostic accuracy. Notably, a same-day regimen significantly enhances both cleansing quality and DY, suggesting that the timing of administration is more critical than the laxative's dosage. |
| Safety and efficacy of same-day discharge after gastric peroral endoscopic myotomy for gastroparesis: A systematic review and meta-analysis.
This meta-analysis demonstrates no significant difference in outcomes between patients with same-day discharge vs overnight admissions after G-POEM. |
| Utility of repeat colonoscopy attempt after failed colonoscopy: a systematic review and pooled analysis.
Repeat colonoscopy attempt in cases of incomplete colonoscopy yielded a commendable CIR of 95%. Importantly, this also enables potential therapeutic intervention of neoplasia and adenomas. |
RCT, clinical trials, retrospective studies, etc…
| Aliment Pharmacol Ther |
|---|
| Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation.
HBV genotype and EOT biomarkers, including HBcrAg, HBV RNA, and anti-HBc IgG predict SVRel and SBF following NUC cessation. The COBRA score enables pragmatic, individualised risk stratification. |
| Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD, MetALD and ALD.
Patients with SLD, including MASLD, MetALD and ALD, have a significantly higher risk of gastrointestinal cancers compared to the controls. The degree of risk varies according to the underlying liver disease subtype, particularly in relation to alcohol consumption. These findings underscore the importance of implementing risk-stratified cancer screening strategies in patients with SLD. |
| Am J Gastroenterol |
| A Novel Blood-Based Test for Colorectal Cancer Detection Using Cell-Free DNA Fragmentomics.
This cfDNA-based blood test demonstrated high diagnostic accuracy for CRC and acceptable performance for AA. Its consistent performance across clinical subgroups suggests its potential as an effective noninvasive CRC screening tool. |
| Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome.
In this article, we discuss how clinicians may incorporate additional clinical features and actionable biomarkers to better inform the initial choice of therapy for patients with IBS. Ideally, such a mechanistic approach should be more efficient, and ultimately more effective, leading to improved patient satisfaction and clinical outcomes. |
| Artificial Intelligence Analysis of Endoscopy Outperforms Conventional Endoscopic Scoring for Agreement with Symptoms and Quality of Life in a Phase 3 Ulcerative Colitis Trial.
AI-enabled endoscopic scoring has better agreement with symptomatic remission and HR-QoLs compared to MES and could quantitatively redefine adequate mucosal healing. |
| Artificial Intelligence versus Human Clinicians in Esophagogastroduodenoscopy Appropriateness: A Comparative Study Using Clinical Vignettes.
Temporal and prompt variability highlight the need for multi-run, longitudinal evaluation before clinical adoption. |
| Diagnosis and Management of C. difficile.
The role of conventional fecal microbiota transplantation (FMT), particularly in fulminant CDI, is also addressed, including challenges resulting from FDA policies around stool bank material. We aim to clarify diagnostic and therapeutic approaches and optimize care for patients with CDI. |
| Efficacy and safety of gelatin tannate and tyndallized acid lactic bacteria in adults with chronic diarrhea and altered gut microbiota: A randomized, double-blind, placebo-controlled study.
GT, a medical product that acts through a mechanical action on the gut wall, provides an effective and safe treatment option for adults with chronic diarrhea and an altered fecal microbiota composition. |
| Harnessing Natural Language Processing to Identify Documentation of Serious Illness Communication for Patients with Decompensated Cirrhosis.
NLP is more efficient and as accurate as manual chart review for identifying SIC documentation in the EHR for patients with DC and can be used at scale for quality improvement initiatives and clinical trials. |
| Hypersensitivity to the lactulose nutrient challenge test in irritable bowel syndrome - a non-invasive test of meal-related symptoms.
The LNCT is useful as a non-invasive and physiologic tool to test GI sensory function in relation to a meal. Moreover, overall GI symptom reporting, visceral hypersensitivity, and hydrogen production are important factors involved in postprandial symptoms in IBS. |
| Nebokitug, an anti-CCL24 monoclonal antibody, in patients with primary sclerosing cholangitis: A phase 2 study.
Nebokitug was well-tolerated up to 48 weeks of treatment, and demonstrated numerical biomarker improvements in patients with PSC, particularly in those with moderate/advanced fibrosis. |
| Prospective validation of the first FDA-approved computer-aided quality (CAQ) assessment tool for colonoscopy: An initial clinical experience.
CAQ reliably measures withdrawal time and cecal intubation, but AI-based BBPS scoring requires further validation before integration into current paradigms of colonoscopy quality. |
| Sequence Analysis Identifies Clusters of Antibiotic Use after the First Episode of Pouchitis in a Population-based Study that May Represent High-Risk Phenotypes.
High risk phenotypes following an initial episode of pouchitis suggest the need to evaluate the role of secondary prevention strategies. |
| Temporal and demographic trends in alcohol-related-cirrhosis, alcohol-related hepatitis, and non-alcohol-related cirrhosis hospitalizations from 2012-2023: A population-based study in Alberta, Canada.
Between 2012-2023, we report increasing AH hospitalization rates, and stable AC/NAC hospitalization rates. During COVID-19, AC and AH hospitalization rates increased for those from rural areas and lower income areas for AH. |
| The risk of psychiatric disorders in patients with autoimmune hepatitis: a nationwide registry-based follow-up study.
This nationwide study showed that the risk for psychiatric disorders was similar in patients with AIH and in population comparators. |
| Clin Gastroenterol Hepatol |
| Histologic remission and mortality in patients with inflammatory bowel disease: a nationwide cohort study.
Both histologic inflammation and clinical activity of IBD were associated with increased all-cause mortality, suggesting that improved disease control may reduce mortality risk in IBD. |
| Endosc Int Open |
| Biliary stents reshape the bile microbiome in the absence of cholangitis.
These findings suggest that stents may predispose to opportunistic colonization, providing a potential mechanistic link to future cholangitis. Recognizing such preclinical dysbiosis may inform tailored antimicrobial strategies and future stent design. |
| Optimizing self-expandable metallic stent placement for malignant ileocecal obstruction: Role of pre-stenting contrast enema and device selection.
SEMS placement in the ileocecal region is technically more challenging than in other right-sided segments. Procedure optimization - potentially aided by CLEAN, tapered hoods, and experienced operators-may help overcome anatomical difficulties while maintaining safety. |
| Endoscopy |
| Open Zenker's Peroral Endoscopic Myotomy: A Comparative Analysis Of This Modified Technique Versus The Standard Zenker's Peroral Endoscopic Myotomy Approach.
OZ-POEM demonstrates comparable clinical, technical and safety outcomes as Z-POEM, with significantly shorter procedural duration and closure cost. It simplifies Z-POEM technique, making it more scalable for trainees and therapeutic endoscopists. |
| Performance measures for endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative - Update 2025.
The European Society of Gastrointestinal Endoscopy (ESGE) recommends that endoscopy services across Europe adopt the following six key performance measures for endoscopic ultrasound (EUS) for monitoring and evaluation in daily practice at center and endoscopist level: (1: ) informed patient consent (100 % of procedures); (2: ) adequate documentation of landmarks (≥ 90 % of procedures); (3: ) structured training and supervision for trainees, preferably using assessment tools (≥ 20 %); (4: ) standardized description of pancreatic cystic lesions (≥ 85 %); (5: ) diagnostic tissue acquisition with EUS-guided fine-needle aspiration/fine-needle biopsy for solid lesions (≥ 85 %); (6: ) adverse events (< 5 % in cystic and < 3 % in solid lesions). A recommendation to administer antibiotics for EUS-guided puncture of cystic lesions, included in the previous ESGE quality improvement document, has been omitted in the current version based on recent evidence. |
| Gastroenterology |
| Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening.
For HCC screening in MASLD, ALD, and cured-HCV cirrhosis, reducing the AFP threshold to ≥10 ng/mL would substantially increase sensitivity while maintaining very high specificity. |
| Postoperative Ileum Transcriptomics Implicate Sex-Biased Mechanisms in Crohn's Disease Recurrence.
In recurrent disease of the postoperative neoterminal ileum, markedly greater dynamic ranges of gene expression occur in male compared with female patients. Pathway analyses implicate numerous nuclear hormone pathways, highlighting new mechanisms for therapeutic targeting beyond pro-inflammatory cytokine blockade. This study identifies key covariates and pathways of disease recurrence, many of which are distinct from drivers of initial disease susceptibility. |
| Retraction Notice to: "A Rare Cause of Peri-esophageal Cystic Lesion": Gastroenterology 2023;164:191-193.
As such, this article represents a misuse of the scientific publishing system. The Publisher reached out to the authors for an explanation, but they did not respond. |
| The Disease Burden of Helicobacter pylori Beyond Gastric Cancer: Quantifying the Forgotten Potential Benefits of Mass Eradication.
Omitting PUD and dyspepsia as outcomes in studies on H pylori screen-and-treat may substantially underestimate benefits. Incorporating these diseases alongside GC into cost-effectiveness and policy analyses, therefore, may improve the evaluation of H pylori screen-and-treat programs. The actual benefit depends on the extent to which H pylori triggers an irreversible pathway to disease early in life. |
| Gastrointest Endosc |
| Clinical Characteristics and Outcomes of Patients Managed without Repeat Endoscopic Resection for Metachronous Esophageal Squamous Neoplasia.
For select patients with metachronous ESCN, repeat ER may not be feasible due to lesion complexity or systemic conditions. Adopting personalized treatment strategies that balance safety and efficacy is essential for optimal long-term management. |
| Comparative Safety and Efficacy of Remimazolam versus Propofol for ERCP with the patient Under Deep Sedation: A Multi-center Randomized Controlled Trial.
Remimazolam is a safe and effective alternative to propofol for sedation during ERCP, demonstrating comparable sedation efficacy, higher patient satisfaction, reduced injection site pain, and fewer moderate-to-severe cardiopulmonary adverse events. Remimazolam thus has strong clinical utility, particularly in patients at a higher risk of sedation-related complications. |
| Impact of a sustainability intervention on the carbon footprint and processing expenses of endoscopic waste.
The sustainability intervention demonstrated a meaningful impact, with education and the adoption of sustainable practices - namely waste segregation and recycling - leading to reductions in carbon footprint, waste management costs, and overall waste generation. |
| Precipitation-based versus filtration-based liquid-based cytology in EUS-FNB specimens of solid pancreatic masses: a prospective, randomized trial.
For EUS-guided FNB of solid pancreatic masses, the SurePath™ LBC technique demonstrated superior diagnostic performance, faster interpretation times, and better preservation of cytomorphological features than ThinPrep®. These findings suggest that SurePath™ should be the preferred LBC method for evaluating EUS-guided FNB of pancreatic masses. |
| Gut |
| Acute upper gastrointestinal bleeding in the UK: 2022 audit update.
Despite a higher-risk case mix and incomplete adherence to guidelines (notably in transfusion thresholds and risk stratification), outcomes in AUGIB have improved. The observation of increased mortality with liberal transfusion above 80 g/L in stable patients reinforces the importance of restrictive transfusion practice. Quality improvement initiatives focused on risk stratification, endoscopic training and multidisciplinary care could further enhance outcomes in the UK and internationally. |
| Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis.
This study emphasises the critical role of intestinal macrophages in preventing the dissemination of luminal bacteria and highlights the multifaceted breakdown of the intestinal barrier in cirrhosis and the importance of the gut-vascular barrier. |
| Hepatology |
| Development and validation of a non-invasive score for at-risk metabolic dysfunction-associated steatohepatitis in individuals with obesity undergoing bariatric surgery.
-The FMO is an accurate and cost-effective non-invasive score for at-risk MASH identification in populations with obesity. |
| NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.
NEDP1 acts as a tumor suppressor in HB by modulating the NEDDylation status of key regulatory proteins, particularly CAND1. Restoration of NEDP1 activity suppresses tumorigenesis and metastasis, underscoring the NEDDylation pathway as a promising therapeutic target. CAND1 is proposed as a potential prognostic biomarker and actionable oncogenic driver in HB. |
| Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.
In this large global biopsy-based MASLD cohort, advanced fibrosis was highly prevalent and strongly linked to T2D. Both histologic fibrosis and NITs were independent predictors of mortality and clinical outcomes, underscoring the prognostic value of fibrosis assessment with non-invasive tests. |
| The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.
Vaccinating with conserved regions of genotypes 1-6 or sequentially vaccinating with genotype-1a and genotype-3a immunogens are two novel approaches to generate cross-reactive T cells. The proportion of intergenotypic cross-reactive T cells generated was higher using the conserved region antigen. |
| J Neurogastroenterol Motil |
| Bali Chronic Constipation Roundtable Report: Chronic Constipation Management in Asia.
The Bali Chronic Constipation Roundtable highlighted Asia's need for region specific diagnostics and management. Addressing diagnostic and treatment gaps will improve outcomes, while ongoing researcher clinician policy collaboration must standardize guidelines, advance research, and ensure equitable care across Asia. |
| Combined Gastric Alimetry and Gastric Emptying Scintigraphy Testing Increases Clinician Certainty in the Diagnosis and Management of Suspected Gastroparesis.
The combined GES and BSGM test results significantly enhanced diagnostic and management confidence in patients with suspected gastroparesis within a tertiary center. |
Plenty of the editorials are available as full text through the publisher website using the provided link
| Aliment Pharmacol Ther |
|---|
| Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease. |
| Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD-Insights From a National Analysis. |
| Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion.
Sizable gaps persist in the evidence base for IUS in IBD. Addressing these gaps through robust, multicentre studies and consensus-driven frameworks is essential to optimise the clinical and research utility of IUS in IBD management. |
| Gastroenterology |
| An Evidence-Based Practical Review on Common Benign Anorectal Disorders: Hemorrhoids, Anal Fissure, Dyssynergic Defecation, and Fecal Incontinence.
Surgical interventions must balance long-term effectiveness with potential risks. Key topics for future research are proposed. |
| Gastroenteropancreatic Neuroendocrine Tumors.
Additionally, research is needed to better define GEP-NET subtypes that are appropriate for endoscopic therapy as well as to understand long-term outcomes after endoscopic resection. Given the important role that endoscopy has in the diagnosis and management of GEP-NETs, increased recognition of and knowledge about these tumors is critical for the gastroenterology community. |
| Gastrointest Endosc |
| A note from the Editor-in-Chief. |
| Combined endoscopy and functional lumen imaging probe for point-of-care diagnosis of esophageal motility disorders: promising preliminary results of changing our practice. |
| Delayed perforations after colorectal endoscopic submucosal dissection: Is there a role for endoscopic closure? |
| EUS-guided fine-needle biopsy for genomic profiling of solid pancreatic masses: Are we still smelling the ROSEs? |
| EUS-guided radiofrequency ablation for unresectable pancreatic adenocarcinoma: Is the reward worth the risk? |
| Gastric peroral endoscopic myotomy: perfecting the technique and the approach. |
| Prophylactic pancreatic duct stent removal: with great power comes great responsibility. |
| J Hepatol |
| Editorial: Genetic Drivers of MASLD Histological Progression. |
misc publications eg case reports, tools of the trade, images of the month, etc…
| Am J Gastroenterol |
|---|
| Letter to the Editor. |
| Pelvic Health Physical Therapy: What Every Gastroenterologist Should Know. |
| Redefining Success in Inflammatory Bowel Disease Beyond Inflammation: Time to Aim Higher! |
| Social Determinants of Health in Gastroenterology Practice. |
| Clin Gastroenterol Hepatol |
| Optimizing Scheduling Efficiency and Throughput in the Endoscopy Unit: Best Practices and Strategies to Improve Unit Utilization. |
| Endoscopy |
| A case of tumor-related hemobilia successfully treated with radiofrequency ablation diagnosed by peroral cholangioscopy. |
| A case presentation of a metachronous superficial epiglottic lesion excised by endoscopic submucosal dissection. |
| A case presentation of duodenal gastric epithelial neoplasm-fundic-gland mucosa lesions. |
| A successful treatment of esophagomediastinal fistula following endoscopic submucosal dissection: tube-in-tube endoscopic vacuum therapy. |
| Combined approaches to rescue an entrapped pancreatic stone basket. |
| Contrast enhanced endoscopic ultrasound and detective flow imaging for characterization of gastric neuroendocrine neoplasms. |
| Endoscopic antireflux mucoplasty using the reopenable-clip over-the-line method for refractory gastro-esophageal reflux disease. |
| First case of hemorrhoidal carcinoma in a fistulotomy scar: successful per-anal endoscopic myectomy despite severe fibrosis. |
| From failure to success: endoscopic management of difficult pancreatic cannulation after ampullary adenoma resection. |
| Minimally invasive retrograde esophageal endoscopic submucosal dissection via gastrostomy using a thin therapeutic endoscope. |
| Needle tract seeding after fine-needle aspiration for pancreatic cancer assessed by endoscopy and endoscopic ultrasound. |
| Novel endoscopic suture anchor device for scarred perforation closure: a survival porcine pilot study. |
| One stone for two birds: Successful treatment of splenic artery aneurysm and gastric varices using endoscopic ultrasound-guided coil and glue embolization. |
| Peroral cholangioscopy-guided laser lithotripsy using a thin cholangioscope under balloon enteroscopy for Roux-en-Y anastomosis. |
| Small but mighty: cylindrical transparent cap-assisted cholangioscopic electrohydraulic lithotripsy and stone extraction for the treatment of difficult common bile duct stones. |
| Staged endoscopic submucosal dissection for a giant gastric fundus lesion: a strategy for the incompletable. |
| Targeted cholangioscopy-guided biopsies through the mesh of biliary metal stents - a challenging diagnosis of perihilar cholangiocarcinoma. |
| Traction-assisted endoscopic submucosal dissection of a neuroendocrine tumor in the gastric body of a patient with autoimmune gastritis. |
| Use of biliary metal stents and defect-closure systems: a new strategy to treat refractory benign esophageal strictures. |
| Gastroenterology |
| A rare etiology of hepatic steatosis. |
| Food for Thought in IBS: Should we go Mediterranean? |
| Global Discrepancies in Inflammatory Bowel Disease Care Reflect Health Care Expenditure Per Capita. |
| Hepatitis B Vaccination: A remarkable success story that must continue. |
| Language barriers limit clinical trial accessibility for patients with gastrointestinal cancer. |
| Perspectives on the issues of indeterminate/grey zones of chronic HBV infection. |
| The Impact of Gastroenterologist and Patient Gender on Health Care Utilization Following Initial Gastroenterological Consultation. |
| Gut |
| Diabetes and pancreatic cancer: a complex and confounding interplay. |
| Thrombospondin-2: a promising but unproven biomarker for MASH. |
| Hepatology |
| A bright future: Sustainable treatment of gastric varices. |
| A strategic plan of RETREAT: Time to translate validation into action. |
| Fellows' Corner. |
| It's not you, it's MET: When MASH gets personal. |
| Metabolic reprogramming in macrophages: A glutamine rescue in β-catenin mutant hepatocellular carcinoma. |
| Radiomics beyond the visible - Decoding tumor heterogeneity to guide combination therapy of intermediate stage HCC. |
| Reply: The missing link-Return to drinking as a composite endpoint component requires deeper alcohol use disorder characterization. |
| Starve the tumor, fuel the immune fire: Short-term starvation enhances checkpoint blockade via macrophage reprogramming in HCC. |
| J Hepatol |
| From the Editor's Desk. |
Letters to the editors and authors’ replies
| Aliment Pharmacol Ther |
|---|
| Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease-Authors' Reply. |
| Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD-Insights From a National Analysis. Authors' Reply. |
| Letter: Methodological Caveats in Zhang et al.-Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension. |
| Clin Gastroenterol Hepatol |
| DIETARY EMULSIFIERS AND THE GASTRO-INTESTINAL TRACT: THE JURY IS STILL OUT, YET THE DOCTOR WARRANTS CAUTION - AUTHOR'S REPLY. |
| The influence of dietary emulsifiers on the gastrointestinal tract - the jury is still out. |
| Gastroenterology |
| Artificial Intelligence in Inflammatory Bowel Disease Management. |
| Clarifying Gastric Cancer Risk After Helicobacter pylori Eradication. |
| Comments on "Eradication Therapy to Prevent Gastric Cancer in Helicobacter pylori-Positive Individuals". |
| Comments on "Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori". |
| Comments on Statistical and Mechanistic Aspects of Perforin and CXCL9 in IBD-Induced Depression. |
| Concerns Regarding the Clinical Applicability and Statistical Analysis of TXI in the deTXIon Trial for Colorectal Lesion Detection. |
| Correspondence on "Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori". |
| Critical Analysis of "Remodeling the Colon With Ileal Properties to Treat Short Bowel Syndrome". |
| Essentiality of liver failure in acute on chronic liver failure and its implications. |
| Methodological Considerations for Further Enhancing the Clinical Impact of the deTXlon Study. |
| Methodological Considerations in the Meta-Analysis on Helicobacter pylori Eradication for Gastric Cancer Prevention. |
| Multi-Mechanistic Persistence of Gastric Cancer Risk Post-Helicobacter pylori and Surveillance Strategies. |
| Reconsidering Genomic Stability in Esophageal Cancer Stem Cells: Insights from Chromothripsis. |
| TXI Raises Detection of Non-Neoplastic Polyps Without Improving Clinically Meaningful Neoplasia Endpoints. |
| Gastrointest Endosc |
| Advancing the application of repeat peroral endoscopic myotomy with technical insights and future directions. |
| Evaluating model stability in EMR versus surgery analysis. |
| Fully covered self-expandable metal stents for type II perforations: Better outcomes or just better statistics? |
| Further considerations on the timing of endoscopic necrosectomy for walled-off pancreatic necrosis. |
| Is the superiority of fully covered self-expandable metal stents for ERCP-related type II perforations overstated? A commentary on recent evidence and clinical heterogeneity. |
| Limitations when using the Manufacturer and User Facility Device Experience database to analyze real-world data of the performance and safety of the Ovesco clip systems. |
| Phosphorus-32 implantation combined with chemotherapy outperforms chemotherapy alone in locally advanced pancreatic cancer: mechanistic insights and future implications. |
| Repeat peroral endoscopic myotomy: technical difficulty and risk factors. |
| Gut |
| Does the benefit of haemostatic powder differ by Forrest classification in non-variceal upper gastrointestinal bleeding? |
| Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis. |
| J Hepatol |
| Divergent sex-specific trends in alcohol-attributable cirrhosis and liver cancer mortality: population-level insights complementing NHANES findings. |
| MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response. |
| Prevalence and Antiviral Treatment Rate in Chronic Hepatitis B Patients with a Family History of HCC. |
| Reassessing the L. reuteri/ indole-3-lactic acid pathway in TACE-related liver injury. |
| Systemic screening and management strategies for early portopulmonary hypertension. |